We apologize your item could not be found. Not all items are listed on our website. Please contact your account manager for details regarding your searched item.
Material number (eg: xxxxxxxxxxx) no space or hyphen needed.
No Results Found
Employees at West’s Eschweiler, Germany, facility celebrated the holidays with a party that had some very generous results. The party took place on December 15, 2012, with more than 520 employees attending and participating in a lottery for three superb prizes, including a flat-screen television, digital camera and gift voucher for gas.
The result? Three very happy employees and more than €4,000 raised to aid Fortschritt, an organization that helps to care for children and teenagers with cerebral disabilities.
“It was a very special project,” said Helga Bayer-Steguweit, who helped to organize the party. “And a wonderful way to say ‘happy new year’ to children in need in our region.”
<em>General chapter USP <382> Elastomeric Component Functional Suitability in Parenteral Product Packaging/Delivery Systems</em> is slated to become official on December 1, 2025. This allows five years from the date of publication in December of 2020 for stakeholders to implement the new testing requirements for full compliance. While that date seems to be far off in the future, there has been interest in early adoption of the new chapter and implementation of the various tests it requires.
In the first of three installments of our video tour of our Scottsdale, AZ, plant, Jeff Kyle, Sr. Director Operations and Supply Chain, speaks to what gets him excited about working at West: The knowledge that they are helping to improve the lives of patients by creating innovative drug packaging and delivery systems.
Pharmaceutical industry focus on issues of extractables and leachables from packaging/delivery systems began during the mid-1990’s. Since then, regulatory agencies have become more educated, and drug product formulations have become more complex, which makes the need for a robust extractables and leachables program that much more critical. Failure to properly evaluate extractables and leachables has had a negative impact on many pharmaceutical companies, e.g., late-stage stability failures, submission delays, and recalls. To avoid this, the question is – where to start?
The number of people fleeing from war to seek refuge in Europe is increasing every day. Many people arrive with harrowing tales of overcoming long distances carrying small children in their arms, having nothing but the clothes on their backs.
“Waiter, what’s this fly doing in my soup?”<br>Answer: “The backstroke”
English
Chinese
